FDA Approved: FLECAINIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for flecainide acetate from Hikma Pharmaceuticals USA Inc., approving changes to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Cardiac Arrhythmia
• Paroxysmal Supraventricular Tachycardia
• Ventricular Tachycardia

Drugs mentioned

• Flecainide acetate (flecainide acetate)

Snippet

SUPPL AP for FLECAINIDE ACETATE (FLECAINIDE ACETATE)